Jump Financial, LLC Ocular Therapeutix, Inc Transaction History

Jump Financial, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.45 - $9.23 $796,200 - $1.14 Million	-123,442 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$4.2 - $8.69 $336,516 - $696,268	80,123 Added 184.96%	123,442 $844,000
Q1 2024 May 13, 2024	BUY	$3.85 - $10.93 $166,778 - $473,476	43,319 New	43,319 $394,000
Q2 2023 Oct 21, 2024	BUY	$4.6 - $7.64 $498,179 - $827,412	108,300 Added 96.7%	220,300 $1.14 Million
Q2 2023 Aug 07, 2023	BUY	$4.6 - $7.64 $498,179 - $827,412	108,300 Added 96.7%	220,300 $1.14 Million
Q1 2023 Oct 21, 2024	SELL	$2.79 - $6.27 $31,923 - $71,741	-11,442 Reduced 9.27%	112,000 $590,000
Q1 2023 May 03, 2023	BUY	$2.79 - $6.27 $312,480 - $702,240	112,000 New	112,000 $590,000
Q4 2021 Feb 10, 2022	SELL	$6.16 - $12.07 $371,448 - $727,821	-60,300 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$9.7 - $14.34 $165,006 - $243,937	-17,011 Reduced 22.0%	60,300 $603,000
Q2 2021 Aug 13, 2021	BUY	$13.43 - $19.16 $1.04 Million - $1.48 Million	77,311 New	77,311 $1.1 Million
Q4 2020 Feb 12, 2021	SELL	$7.91 - $22.95 $128,142 - $371,790	-16,200 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$7.36 - $9.87 $119,232 - $159,894	16,200 New	16,200 $123,000

171

138M

150K

225K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $654M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.